Excerpt: We are writing to express grave concerns regarding a regulation … that would change longstanding policy regarding the 1984 Hatch-Waxman Act. The proposed regulation would allow generic manufacturers to alter an abbreviated new drug application (ANDA) label without the FDA’s prior approval. To read the letter, click here.
Air-Conditioning, Heating, and Refrigeration Institute Alabama Automotive Manufacturer's Association
Americans for Tax Reform Campaign for Liberty Concerned Women for America
American Chemistry Council American Coke & Coal Chemicals Institute American Iron and Steel Institute
To read DOE's, response, click here.
Excerpt: "These actions raise questions not only about whether the Treasury Department’s new climate policies comport with its duties and functions, but also the practical impact on U.S. international humanitarian goals, trade policies, and foreign commerce." To read the letter, click here.